Macrogenics reported $-39935000 in Pre-Tax Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbvie ABBV:US $ 6290M 282M
Cerulean Pharma CERU:US $ -9.16M 1.84M
Daiichi Sankyo 4568:JP Y 47062M 72506M
Dicerna Pharmaceuticals DRNA:US $ -40.27M 10.3M
Eli Lilly And LLY:US $ 1988.6M 80.6M
Epizyme EPZM:US $ -64.36M 5.91M
Five Prime Therapeutics FPRX:US $ -20.85M 0M
Genmab GEN:DC DK 422M 1002M
Geron GERN:US $ -29.57M 1.75M
Immunogen IMGN:US $ -30.74M 3.31M
Johnson & Johnson JNJ:US $ 7776M 515M
Karyopharm Therapeutics KPTI:US $ -53448000 3.82M
Macrogenics MGNX:US $ -39.94M 11.34M
Regeneron Pharmaceuticals REGN:US $ 3898.3M 2658.7M
Xencor XNCR:US $ 52.25M 54.74M